Skip to content

Calendula ointment effect on phlebitis induced by infusion of dextrose 50% through the peripheral veins

The effect of warm moist compresses Calendula ointment Infusion in phlebitis of dextrose 50% through the peripheral veins in Emam Khomeini hospital

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017060334306N1
Enrollment
128
Registered
2017-06-18
Start date
2016-12-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phlebitis. Phlebitis and thrombophlebitis

Interventions

The intervention groups: Calendula ointment (Dine) use 2.5 g every 8 hours for 3 over skin days after the onset of phlebitis and the other intervention group warm wet compress use 20 minutes every 8 h
Treatment - Drugs

Sponsors

Vice chancellor for research Tehran Azad University Medical
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 79 Years

Inclusion criteria

Inclusion criteria: Participants including major eligibility criteria: Lack of a history of asthma and allergy to Calendula ointment; Lack of intravenous anticoagulant steroid; Having age between 20-70; Having consciousness and the ability to participate in the study; Lack of skin diseases in the area of phlebitis; Phlebitis caused by infusion of dextrose 50%. Participants excluding major eligibility criteria; Lack of desire to continue cooperation in the study; Failure to use correct and timely Calendula ointment and warm moist compresses during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Calendula ointment healing effect on phlebitis. Timepoint: 3 days after the intervention. Method of measurement: Scale Jackson.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahereh Nasrabadi

Islamic Azad University, Tehran Medical Branch

taherehnasrabadi2009@gmail.com+98 21 2263 4874

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026